Retrospective Analysis of Clinical Features, Treatment and Outcome of Coital Injuries of the Female Genital Tract Consecutive to Consensual Sexual Intercourse in the Limbe Regional Hospital

e22518 Background: Rhabdomyosarcoma is a rare tumor in children and adolescents, presenting 3% to 4% of all pediatric cancers. The female genital tract is considered as a favorable site of childhood RMS. The outcome has improved significantly during the last two decades, attributed to risk stratification and multimodality management of these challenging tumors. Here we present the clinical features and treatment results of girls with genital tract rhabdomyosarcoma to discuss. Methods: Fourteen girls with vaginal and uterine servical rhabdomyosarcoma younger than 18 years of age diagnosed and followed up between the years of 1995 and 2019 were included in this analysis. The clinical features and treatment results of patients were recorded from patient files and hospital information system retrospectively. Results: There were seven cases with vaginal and seven with uterin cervical carcinoma. All patients presented with polypoid masses protruding from the vagina. Median age of patients at diagnosis was 71 months (range 8-200 months). The IRS modified TNM staging was stage I for all the patients. All cases had embryonic type of RMS except one with alveolar type. All patients were treated with surgery and adjuvant chemotherapy, three received radiotherapy additionally. All achieved complete remission. Four patients experienced tumor relapse, 1 patient died with progressive disease. The median follow-up time was 75 months (7-271 months) for 13 patients who were alive with remission. Conclusions: Rhabdomyosarcoma is a rare sarcoma with a higher incidence in children and adolescents. With current treatment strategies, female genital tract rhabdomyosarcomas have a good prognosis. Favorable prognostic factors such as early stage at diagnosis and a favorable histology may contribute to the excellent observed survival. All parties who had involved on the care of these girls must be aware of the high survival with proper treatment to avoid treatment related morbidities and mortalities. Because of the rareness of the disease we wanted to share our experience.

Download Full-text

Female genital tract congenital malformations and the applicability of the ESHRE/ESGE classification: a systematic retrospective analysis of 920 patients

Archives of Gynecology and Obstetrics ◽

10.1007/s00404-018-4749-x ◽

2018 ◽

Vol 297 (6) ◽

pp. 1473-1481 ◽

Cited By ~ 2

Author(s):

Dorit Schöller ◽

Marieke Hölting ◽

Diana Stefanescu ◽

Helen Burow ◽

Birgitt Schönfisch ◽

...

Keyword(s):

Retrospective Analysis ◽

Genital Tract ◽

Congenital Malformations ◽

Female Genital Tract ◽

Female Genital

Download Full-text

Gynaecological cancers

InnovAiT Education and inspiration for general practice ◽

10.1177/17557380211011495 ◽

2021 ◽

pp. 175573802110114

Author(s):

Sarah Knapp ◽

Lisa Henderson ◽

Timothy Duncan ◽

Thomas Gray

Keyword(s):

Risk Factors ◽

Clinical Features ◽

Secondary Care ◽

Genital Tract ◽

Female Genital Tract ◽

Gynaecological Cancer ◽

Vulval Cancer ◽

The Uk ◽

Female Genital

Gynaecological cancers are malignancies involving the female genital tract, of which there are five types: ovarian, uterine, cervical, vaginal and vulval cancer. Every year in the UK, more than 21 000 women are diagnosed with a gynaecological cancer and there are 8000 deaths. The NHS is aiming for earlier diagnosis, and campaigns from various UK cancer groups are hoping to increase awareness among women. This article will discuss the epidemiology, risk factors and clinical features of gynaecological cancers and provide a summary of investigation and management in primary and secondary care.

Download Full-text